Robert Schlagenhaufer

Title: The Innovative Contributions of Robert Schlagenhaufer

Introduction

Robert Schlagenhaufer is a notable inventor based in Starnberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of genetic testing. His work focuses on methods that enhance the detection of genetic mutations, which can have important implications for patient care.

Latest Patents

One of Schlagenhaufer's key patents is titled "Method for determining the presence of at least one allele of a GSTT1 deletion mutant." This innovative method involves a PCR assay designed to detect the presence of at least one GST1*0 allele. The process utilizes two primers, one from the sequence upstream of the deletion area and the other from the sequence downstream. The production of the corresponding DNA fragment in the PCR is then verified. This method is particularly useful for testing patients to determine their susceptibility to toxins or their sensitivity to certain therapeutic agents.

Career Highlights

Schlagenhaufer is associated with Epidauros Biotechnologie AG, a company that focuses on biotechnological advancements. His work at Epidauros has allowed him to contribute to the development of innovative solutions in genetic testing. With a patent portfolio that includes 1 patent, he has established himself as a valuable asset in the field.

Collaborations

Throughout his career, Schlagenhaufer has collaborated with esteemed colleagues such as Raimund Sprenger and Ulrich Brinkmann. These partnerships have fostered an environment of innovation and have led to advancements in their shared field of expertise.

Conclusion

Robert Schlagenhaufer's contributions to biotechnology, particularly in genetic testing, highlight the importance of innovation in healthcare. His patented methods provide valuable tools for understanding genetic predispositions, ultimately benefiting patient care.